Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study

Author Correction to: Diabetes Ther (2018) 9:363 –371
Source: Diabetes Therapy - Category: Endocrinology Source Type: research